3D Bio-printing

Final frontier – 3D bioprinting in space

A strategic partnership between CELLINK and Made in Space promises advances for drug screening and cancer treatments. CELLINK, a Swedish bioprinter manufacturer, has announced a...

University of Minho to spin out bioprinting start-up

Research developments create a company focused on meniscus regeneration; seed funding planned for early 2020. One of the leading speakers at the recent 3D Bioprinting...

Interview: 3D bioprinting realties and timescales

After a unique 3D bioprinting research symposium in London we chat with UCL's expert: Dr Deepak Kalaskar  There's something about being at conferences with early-stage...

Exclusive: Interview with US presidential candidate

Zoltan Istvan to challenge Trump in 2020; solving Longevity is at the top of his agenda. Last week, the transhumanist activist Zoltan Istvan announced his...

Latest articles

Insurer puts down £20m to research an aging rethink

A new partnership between Legal & General and Edinburgh University aims to address the societal and economic implications of an aging society. The world is...

23andMe redundancies: DNA test market decline?

Could layoffs at 23andMe be a sign that the consumer appetite for genetic testing is declining? We expect consumer markets to transition to more...

Singapore agetech – ones to watch in 2020

Singapore thrives on its prime location at the crossroads of Asia's biggest markets, low business tax and great IT infrastructure; it is well-positioned to...

Innovating organ-on-chip to accelerate research

BIOFABICS brings custom design tools to biofabrication. While still in its infancy, organ-on-chip (OOC) technology is quickly becoming a key growth segment in the Longevity...

Sign-up for daily news on the research, investments and technologies driving the Longevity market.

Sign-up for daily news on the research, investments and technologies driving the Longevity market.